GlassScriptPhysician profile
Lanie K Huffman
NPI 1790983906
$2,997.15
in general payments reported to CMS, 2019-2025
38 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $252 · 2021: $419 · 2022: $396 · 2023: $513 · 2024: $480 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $461.43 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $416.49 | 2019-2023 | Puraply |
| Ani Pharmaceuticals, INC. | $392.31 | 2022-2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $176.03 | 2019-2025 | Vlp Mini-Mod, Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Stryker Corporation | $166.86 | 2020-2025 | Easyfuse, 7 X 23mm Citrelock Implant, Ortholoc 3di |
| Depuy Synthes Sales INC. | $163.05 | 2023-2025 | Motoband, N/A, Healix Knotless Peek |
| Paratek Pharmaceuticals, INC. | $151.04 | 2020-2025 | Nuzyra |
| Sandoz INC. | $144.65 | 2019-2020 | |
| Orthofix Medical, INC. | $93.74 | 2022-2025 | Physio-Stim |
| Bioventus LLC | $92.75 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $82.89 | 2019-2022 | |
| Amgen INC. | $60.53 | 2024-2025 | Krystexxa |
| Aap Implants INC | $58.99 | 2023 | |
| Djo, LLC | $38.82 | 2021-2023 | Donjoy |
| Zimmer Biomet Holdings, INC. | $37.95 | 2020-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.98 | 2024-2025 | |
| Arthrosurface Incorporated | $29.89 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $29.71 | 2019-2020 | |
| Nabriva Therapeutics, Plc | $28.31 | 2021-2022 | |
| Glenmark Therapeutics INC. | $28.00 | 2019 | |
| Medtronic, INC. | $26.31 | 2024 | Intellis Adaptivestim |
| Tactile Systems Technology INC | $26.29 | 2019-2025 | Nimbl, Flexitouch Plus |
| Dynasplint Systems INC. | $24.03 | 2025 | Dynasplint |
| Kerecis Limited | $22.01 | 2022 | |
| Treace Medical Concepts, INC. | $21.59 | 2022 | |
| Nanovis LLC | $20.00 | 2024 | |
| Encore Medical, LP | $18.44 | 2021 | |
| Boston Scientific Corporation | $18.39 | 2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $17.87 | 2022 | |
| Integra Lifesciences Corporation | $16.11 | 2019 | |
| Trilliant Surgical LLC. | $15.67 | 2021 | |
| Heron Therapeutics, INC. | $15.21 | 2021 | |
| Zyla Life Sciences, INC. | $15.11 | 2020 | |
| Averitas Pharma INC. | $14.29 | 2024 | Qutenza |
| Journey Medical Corporation | $13.65 | 2020 | |
| Paragon 28, INC. | $11.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.76 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,850.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lanie Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.